Pre-launch drug access programs can help patients access investigational therapies before they receive regulatory approval and are launched commercially. Based...
Lorenzo D’Angelo is a principal in the Life Sciences Practice of CRA. He is an experienced Life Sciences consultant helping global pharmaceutical, medical device, and medical technology (MedTech) companies with their commercial strategy.
Lorenzo has supported clients in taking strategic decisions as well as implementing them along the product lifecycle: assessing new opportunities, developing a launch strategy and supporting a launch operationally, understanding and segmenting markets and customers to find new opportunities to grow. In these projects he leverages his 7+ years of experience in collaborative scientific / industrial research, project management, market research and analytical and statistical methodologies. In recent work, he supervised projects providing qualitative and quantitative market insights to value opportunities, forecast their potential return and to decide whether to invest into them or not. Geographically, his work is focused onto Europe and the US but includes other growing markets in LATAM and beyond.
Prior to joining CRA, Lorenzo was a research group leader at TU München. He participated actively in scientific conferences around the world and has published book chapters and articles in academic journals. His background in medical device engineering drives him to find new solutions in life sciences that can go from lab development to market launch and beyond.
His areas of specialty include opportunity assessment; market potential forecast; product launch strategy; launch / project playbooks; operational launch support; market and customer segmentation; quant/qual patient journey; growth opportunity identification; market research.